Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ericsson

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Blood|September 1, 1992
Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemiaP Kogner, A Ericsson, G Barbany, et al.
Lakartidningen|April 5, 1995
[Diabetic care evaluated in eight counties. Sweden on its way to the European standard]J Ostman, Y Larsson, U Adamson, et al.
Journal of Computer Assisted Tomography|November 1, 1986
Quantitative study of flow dependence in NMR images at low flow velocitiesF Ståhlberg, B Nordell, A Ericsson, et al.
Acta Neurologica Scandinavica|August 3, 2004
Src family kinase-inhibitor PP2 reduces focal ischemic brain injuryF Lennmyr, A Ericsson, P Gerwins, et al.
Current Medical Research and Opinion|February 19, 2010
Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetesJ Jendle, O Torffvit, M Ridderstråle, et al.
European Journal of Clinical Investigation|November 14, 1997
Human uterine smooth muscle exhibits a very low phosphocreatine/ATP ratio as assessed by in vitro and in vivo measurementsT Steingrímsdóttir, A Ericsson, A Franck, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1992
Motion associated susceptibility artifactsT Bach-Gansmo, A Ericsson, P Leander, et al.
Physical Chemistry Chemical Physics : PCCP|September 29, 2005
Thermotropic phase behaviour of long-chain alkylmaltosidesCaroline A Ericsson, Louise C Ericsson, Vitaly Kocherbitov, et al.
Neurology|April 1, 1970
Effects of Hexobendine on cerebral blood flow and metabolism in cerebrovascular diseaseJ S Meyer, T Kanda, Y Shinohara, et al.
Magnetic Resonance Imaging|January 1, 1994
Measurement of magnetic susceptibility and MR contrast agent concentrationJ Weis, S Nilsson, A Ericsson, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Blood|September 1, 1992
Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemiaP Kogner, A Ericsson, G Barbany, et al.
Lakartidningen|April 5, 1995
[Diabetic care evaluated in eight counties. Sweden on its way to the European standard]J Ostman, Y Larsson, U Adamson, et al.
Journal of Computer Assisted Tomography|November 1, 1986
Quantitative study of flow dependence in NMR images at low flow velocitiesF Ståhlberg, B Nordell, A Ericsson, et al.
Acta Neurologica Scandinavica|August 3, 2004
Src family kinase-inhibitor PP2 reduces focal ischemic brain injuryF Lennmyr, A Ericsson, P Gerwins, et al.
Current Medical Research and Opinion|February 19, 2010
Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetesJ Jendle, O Torffvit, M Ridderstråle, et al.
European Journal of Clinical Investigation|November 14, 1997
Human uterine smooth muscle exhibits a very low phosphocreatine/ATP ratio as assessed by in vitro and in vivo measurementsT Steingrímsdóttir, A Ericsson, A Franck, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1992
Motion associated susceptibility artifactsT Bach-Gansmo, A Ericsson, P Leander, et al.
Physical Chemistry Chemical Physics : PCCP|September 29, 2005
Thermotropic phase behaviour of long-chain alkylmaltosidesCaroline A Ericsson, Louise C Ericsson, Vitaly Kocherbitov, et al.
Neurology|April 1, 1970
Effects of Hexobendine on cerebral blood flow and metabolism in cerebrovascular diseaseJ S Meyer, T Kanda, Y Shinohara, et al.
Magnetic Resonance Imaging|January 1, 1994
Measurement of magnetic susceptibility and MR contrast agent concentrationJ Weis, S Nilsson, A Ericsson, et al.
Pageof 17